PSMB2 Antibody - middle region: FITC (ARP56462_P050-FITC)

The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. PSMB2 is a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.

KCTD9; UBC; KRT13; PSMD14; ASB11; POMP; PSMB8; PSMB7; PSMB6; PSMB5; PYCRL; PSMB4; PSMB3; PSMB1; PSMA7; PSMA6; PSMA5; PSMA4; PSMA3; PSMA1; HOXA2; PSMA2; PARK2; CDK20; ITGA4; GPX2; FN1; DDX49; IQCB1; VCAM1; SULT1A4; TUBB; PSMA8; C11orf58; SEC23A; PSME3; PSM

PSMB2 is strongly supported by BioGPS gene expression data to be expressed in HeLa, Jurkat PSMB2 is supported by BioGPS gene expression data to be expressed in HEK293T, HepG2

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.